Magnetic Resonance Imaging of Polymeric Drug Delivery Systems in Breast Cancer Solid Tumors
Abstract
The overall purpose of this research is to develop a polymeric drug delivery system containing magnetic resonance contrast agents for the treatment of breast cancer. This drug-imaging agent delivery system will allow the follow up of the fate of the drug delivery system and its relation to reduced tumor mass, improved efficacy and reduced toxicity in individual patients. In year two progress was made in the following areas: 1) Synthesis of polymer- contrast agent- doxorubicin conjugates; 2) Physicochemical characterization of polymer- contrast agent- doxorubicin conjugates; and 3) Relaxivity measurements. In addition, a series of polymer- contrast agent conjugates targetable to macrophages were synthesized, characterized, and evaluated in vitro.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2006
- Accession Number
- ADA469974
Entities
People
- Bahar Zarabi
- Hamid Ghandehari
Organizations
- University of Maryland, Baltimore